← FDA Drug Approvals (Drugs@FDA)
GLATIRAMER ACETATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SCINOPHARM TAIWAN · Approved 2025-12-31
Drug application
- FDA Application #
ANDA214741- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- GLATIRAMER ACETATE
- Generic name
- GLATIRAMER ACETATE INJECTION
- Active ingredients
- GLATIRAMER ACETATE
- Dosage form
- INJECTABLE
- Route
- SUBCUTANEOUS
- Marketing status
- Prescription
- Sponsor
- SCINOPHARM TAIWAN
- Manufacturer
- UPSHER-SMITH LABORATORIES, LLC
- First approval
- 2025-12-31
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown